Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosulpiride vs risperidone in schizophrenia
CTR20160303Phase 2Active
- Sponsor
- Shanghai Hechen Pharmaceutical Engineering
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levosulpiride in schizophrenia, sponsored by Shanghai Hechen Pharmaceutical Engineering. Started May 2016; status: active.
02
Drugs
levosulpiride
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20160303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160303.